TGA Approval

ERLOTINIB CIPLA erlotinib (as hydrochloride) 100 mg tablet blister pack (337798)

ARTG ID

337798

ARTG Name

ERLOTINIB CIPLA erlotinib (as hydrochloride) 100 mg tablet blister pack

Sponsor

Cipla Australia Pty Ltd

ARTG Date

April 30, 2021

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

CIPLA AUSTRALIA PTY LTD

https://medical-cdn.nocode.com/drug_tga/ece5bb5513e66bbfecd5f51737afcfe5.pdf

https://medical-cdn.nocode.com/drug_tga/2038f2d2c2d378bf60441addde923b71.pdf

Ingredient Name

erlotinib hydrochloride

Empowering clinical research with data-driven insights and AI-powered tools.

ERLOTINIB CIPLA erlotinib (as hydrochloride) 100 mg tablet blister pack (337798) - TGA 批准文号 | MedPath